- Home
- LYB vs TEVA Comparison
LYB vs TEVA Comparison
Compare LYB & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYB
- TEVA
- Stock Information
- Founded
- LYB 1955
- TEVA 1901
- Country
- LYB United States
- TEVA Israel
- Employees
- LYB N/A
- TEVA N/A
- Industry
- LYB Major Chemicals
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- LYB Industrials
- TEVA Health Care
- Exchange
- LYB Nasdaq
- TEVA Nasdaq
- Market Cap
- LYB 20.3B
- TEVA 21.2B
- IPO Year
- LYB N/A
- TEVA N/A
- Fundamental
- Price
- LYB $42.77
- TEVA $24.28
- Analyst Decision
- LYB Hold
- TEVA Strong Buy
- Analyst Count
- LYB 16
- TEVA 7
- Target Price
- LYB $62.06
- TEVA $25.86
- AVG Volume (30 Days)
- LYB 5.1M
- TEVA 12.1M
- Earning Date
- LYB 10-31-2025
- TEVA 11-05-2025
- Dividend Yield
- LYB 12.74%
- TEVA N/A
- EPS Growth
- LYB N/A
- TEVA N/A
- EPS
- LYB N/A
- TEVA 0.62
- Revenue
- LYB $37,778,000,000.00
- TEVA $16,776,000,000.00
- Revenue This Year
- LYB N/A
- TEVA $4.11
- Revenue Next Year
- LYB N/A
- TEVA $0.40
- P/E Ratio
- LYB N/A
- TEVA $38.84
- Revenue Growth
- LYB 6.37
- TEVA 0.02
- 52 Week Low
- LYB $41.59
- TEVA $12.47
- 52 Week High
- LYB $85.85
- TEVA $25.00
- Technical
- Relative Strength Index (RSI)
- LYB 33.72
- TEVA 77.45
- Support Level
- LYB $45.09
- TEVA $23.61
- Resistance Level
- LYB $48.07
- TEVA $25.00
- Average True Range (ATR)
- LYB 1.52
- TEVA 0.71
- MACD
- LYB -0.21
- TEVA 0.51
- Stochastic Oscillator
- LYB 15.32
- TEVA 88.91
About LYB LyondellBasell Industries NV (Netherlands)
LyondellBasell is a petrochemical producer with operations in the United States, Europe, and Asia. The company is the world's largest producer of polypropylene and also a major producer of polyethylene and propylene oxide. Its chemicals are used in various consumer and industrial end products. Well over half of LyondellBasell's production comes from its North American operations.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.